NDC 51316-577 - Ultra concentrated Daytime/ Nighttime Severe Softgel
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51316-577
- Manufacturer
- CVS PHARMACY, INC | TIME CAP LABORATORIES, INC. | MARKSANS PHARMA LIMITED
- Effective date
- 2026-03-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CVS 647T Ultraconcentratd Daytime & Nighttime severe cold & flu softgels | CVS PHARMACY, INC | TIME CAP LABORATORIES, INC. | MARKSANS PHARMA LIMITED | 2026-03-26 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CLE CCC Warm Medium Light | TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | KW ABSC, INC. | fc90fb8a-44b3-47cd-882e-94ed324ed389 | 2018-11-27 | Warnings | 15FIX9V2JP |
| CLE CCC Warm Medium | TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | KW ABSC, INC. | b585f216-4234-47c5-9a6b-8b133ef48aae | 2018-11-27 | Warnings | 15FIX9V2JP |
| CLE CCC Warm Light | TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | KW ABSC, INC. | 14891e26-b3b6-4545-99b1-da914b7f5629 | 2018-11-24 | Warnings | 15FIX9V2JP |
| Allergy | DIPHENHYDRAMINE HCL | Allegiant Health | c2823bad-540f-4662-8dcc-58e9f0d94efb | 2018-11-07 | Warnings | M012 |
| Nasal Decongestant PE Maximum Strength Non-Drowsy | PHENYLEPHRINE 10 MG | Allegiant Health | 7aef00df-816a-4ea2-a2ad-beed66dd2fe4 | 2018-11-07 | Warnings | M012 04JA59TNSJ |
| Acetaminophen | ACETAMINOPHEN | Walgreen Company | a1cec332-5802-4684-8b7f-6cb98da40e8b | 2018-08-15 | Warnings | 362O9ITL9D |
| Bio Rock Water | ROCK WATER | BioActive Nutritional, Inc. | 178bd16d-0d4f-49d8-866b-8ab3a3c6889d | 2018-07-30 | Warnings | 059QF0KO0R |
| Additox | TRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, BELLADONNA, CHELIDONIUM MAJUS, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM | BioActive Nutritional, Inc. | 319ee2fe-58e3-495e-bf0d-df201f6fbb1c | 2018-07-18 | Warnings | 15FIX9V2JP |
| Pain Relief PM | ACETAMINOPHEN PM | Velocity Pharma | c1c1de91-6a54-4d91-93a9-b6be6d7c7dfb | 2018-05-14 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | Velocity Pharma LLC | bba2ddc5-19e0-4f11-8ff7-7dd7c2d53b50 | 2018-05-14 | Warnings | 362O9ITL9D |
| Xyralid Hemorrhoidal | HEMORRHOIDAL SUPPOSITORIES | Innovus Pharmaceuticals, Inc. | 8a885822-42e7-44e0-82d6-fa967123866e | 2018-05-03 | Warnings | 04JA59TNSJ |
| DEXTROMETHORPHAN HYDROBROMIDE, Guaifenesin, and PHENYLEPHRINE HYDROCHLORIDE | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Westminster Pharmaceuticals, LLC | a58bfb14-28f9-4425-a5a5-aaff4847c979 | 2018-03-14 | Warnings | M012 9D2RTI9KYH 04JA59TNSJ |
| Oxycodone and Acetaminophen | OXYCODONE AND ACETAMINOPHEN | Camber Pharmaceuticals, Inc. | 2a49ee34-6f1d-4ed3-8daa-343723d2a2be | 2018-02-20 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Your Name Cosmetics Mineral Sheet Tint Broad Spectrum SPF 20 | YOUR NAME COSMETICS MINERAL SHEET TINT BROAD SPECTRUM SPF 20 | Mana Products | 657d5090-30a8-46d0-879d-469178aa234d | 2018-01-25 | Warnings | 15FIX9V2JP |
| Childrens Multi-symptom Cold and Fever Liquid | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Wal-Mart Stores, Inc. | 7bf30c75-e867-4a2f-a481-702d7aa96c23 | 2018-01-08 | Warnings | 9D2RTI9KYH 04JA59TNSJ 362O9ITL9D |
| Tukol A | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | Genomma Lab USA, Inc. | 651f0d7c-c76b-434d-95fd-427609b40b46 | 2017-12-28 | Warnings | 9D2RTI9KYH 04JA59TNSJ |
| Acetaminophen | ACETAMINOPHEN | Advance Pharmaceutical Inc. | 3793a17e-13bf-4d27-b8fa-6753b760f820 | 2017-12-22 | Warnings | 362O9ITL9D |
| ACETAMINOPHEN PM | ACETAMINOPHEN PM | Advance Pharmaceutical Inc. | b172226e-8f2a-4d9c-b7c7-dd737b90463a | 2017-12-22 | Warnings | 362O9ITL9D |
| APAP | ACETAMINOPHEN | Advance Pharmaceutical Inc. | aba26f0a-94e4-4919-a3b0-033e3a9598ef | 2017-12-22 | Warnings | 362O9ITL9D |
| APAP | ACETAMINOPHEN | Advance Pharmaceutical Inc. | 5c75dc7f-06ae-440e-90ed-d7753eaa786e | 2017-12-22 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.